DABIGATRAN
Clinical Indication
Venous thromboembolism (treatment and long term secondary prevention)
Date of classification
December 2017
Yellow
Specialist recommendation: Medicines initiated (and stabilised where appropriate) or recommended by a specialist service for prescribing in primary care. Requests should be clearly communicated either through written communication including using approved paperwork if available or verbal means as appropriate .